Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuroactive ligand-receptor interaction pathway refers to the collection of cell signaling events where various neuroactive ligands (such as neurotransmitters, hormones, and neuropeptides) bind to and activate their respective cell membrane receptors, ultimately regulating intracellular signaling and neural function. This pathway encompasses over 300 genes encoding receptors and ligands crucial for neural information processing, cognition, and brain health[2][3]. It features key receptor classes including G protein-coupled receptors, ligand-gated ion channels, and nuclear hormone receptors[3]. Dysregulation in this pathway is associated with neurological and psychiatric disorders (such as Alzheimer’s disease and schizophrenia), cancer, and cardiovascular conditions[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroactive ligand-receptor interaction pathway.